Our MR approach complements these clinical findings by providing genetic evidence that elevated DPP4 expression contributes to HF pathogenesis—potentially through mechanisms such as inflammation and adverse cardiac remodeling—while DPP4 inhibition itself does not exert an indirect detrimental effect on other CVDs. Here, DPP4 is linked to hydrops fetalis.